The Lupus Research Alliance announced that clinical research affiliate Lupus Therapeutics is partnering with the pharmaceutical company, Janssen, to help conduct a Phase 3 trial to test existing drug ustekinumab (Stelara®) as a potential treatment for people with lupus. Stelara® is not approved by the FDA as a treatment of lupus but is indicated for certain other autoimmune diseases.
Called LOTUS, the international study is being conducted in over 200 sites, 20 of which are belong to the Lupus Clinical Investigators Network (LuCIN) overseen by Lupus Therapeutics.
Stelara® is not approved by the FDA as a treatment of lupus but is indicated for certain other autoimmune diseases.
The full press release is available on the Lupus Therapeutics website.
